-
DE
The thyroid hormone receptor is a nuclear protein that binds thyroid hormones and regulates the activity of numerous genes. It plays a central role in metabolism, growth, and development throughout the body.
The thyroid hormone receptor is a nuclear protein that binds thyroid hormones and regulates the activity of numerous genes. It plays a central role in metabolism, growth, and development throughout the body.
The thyroid hormone receptor (TR) is a specialized protein located primarily in the cell nucleus. It belongs to the superfamily of nuclear receptors and acts as a transcription factor, meaning it directly controls which genes are activated or silenced in a given cell. Its primary function is to bind the thyroid hormones triiodothyronine (T3) and thyroxine (T4) and mediate their biological effects in target tissues throughout the body.
There are two main types of thyroid hormone receptors, each encoded by a different gene:
Each receptor type has multiple isoforms that are expressed in a tissue-specific manner and serve distinct physiological roles.
The thyroid hormone receptor operates through the following mechanism:
In the absence of hormone binding, the receptor can act as a repressor and actively silence gene transcription. Binding of T3 relieves this repression and stimulates gene expression.
The thyroid hormone receptor regulates a wide range of vital physiological processes:
Disruptions in thyroid hormone receptor function can lead to serious medical conditions:
Resistance to thyroid hormone is caused by mutations in the TR-beta gene, which result in target tissues failing to respond adequately to T3 and T4. Affected individuals typically show elevated thyroid hormone levels in the blood alongside a reduced or absent tissue response. Symptoms may include rapid heartbeat, attention deficits, growth disturbances, and an enlarged thyroid gland (goiter).
Alterations in the thyroid hormone receptor gene, particularly fusion genes involving TR-beta, have been identified in certain forms of thyroid cancer (e.g., follicular thyroid carcinoma). These mutations can disrupt normal cell growth and contribute to tumor development.
Selectively targeting specific receptor subtypes is a promising area of modern medicine. Selective TR-beta agonists (e.g., resmetirom) are being developed and used to treat liver diseases such as non-alcoholic steatohepatitis (NASH) and to reduce elevated blood lipid levels. Because TR-beta is predominantly active in the liver, this approach aims to achieve therapeutic benefits while minimizing unwanted cardiovascular side effects associated with TR-alpha activation.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.